SK5312000A3 - Use of thiazolidinediones for the treatment of hyperglycaemia - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia Download PDF

Info

Publication number
SK5312000A3
SK5312000A3 SK531-2000A SK5312000A SK5312000A3 SK 5312000 A3 SK5312000 A3 SK 5312000A3 SK 5312000 A SK5312000 A SK 5312000A SK 5312000 A3 SK5312000 A3 SK 5312000A3
Authority
SK
Slovakia
Prior art keywords
hyperglycemia
compound
plasma glucose
glucose levels
pharmaceutically acceptable
Prior art date
Application number
SK531-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK5312000A3 publication Critical patent/SK5312000A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK531-2000A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia SK5312000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
SK5312000A3 true SK5312000A3 (en) 2000-09-12

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
SK531-2000A SK5312000A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (xx)
JP (1) JP2001519382A (xx)
KR (1) KR20010024481A (xx)
CN (1) CN1281359A (xx)
AP (1) AP2000001787A0 (xx)
AU (1) AU9547098A (xx)
BG (1) BG104404A (xx)
BR (1) BR9815219A (xx)
CA (1) CA2306086A1 (xx)
CZ (1) CZ20001297A3 (xx)
EA (1) EA002659B1 (xx)
GB (1) GB9721693D0 (xx)
HR (1) HRP20000255A2 (xx)
HU (1) HUP0003922A3 (xx)
ID (1) ID24521A (xx)
IL (1) IL135513A0 (xx)
NO (1) NO20001898L (xx)
NZ (1) NZ503862A (xx)
OA (1) OA11683A (xx)
PL (1) PL339813A1 (xx)
SK (1) SK5312000A3 (xx)
TR (1) TR200000958T2 (xx)
WO (1) WO1999018943A1 (xx)
YU (1) YU28800A (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
HRP20000255A2 (en) 2001-02-28
TR200000958T2 (tr) 2000-08-21
WO1999018943A1 (en) 1999-04-22
ID24521A (id) 2000-07-20
CN1281359A (zh) 2001-01-24
BR9815219A (pt) 2001-01-02
CZ20001297A3 (cs) 2001-08-15
EA200000419A1 (ru) 2000-10-30
NZ503862A (en) 2003-01-31
PL339813A1 (en) 2001-01-02
EA002659B1 (ru) 2002-08-29
YU28800A (sh) 2003-02-28
NO20001898D0 (no) 2000-04-12
OA11683A (en) 2005-01-12
NO20001898L (no) 2000-06-09
EP1023056A1 (en) 2000-08-02
CA2306086A1 (en) 1999-04-22
KR20010024481A (ko) 2001-03-26
GB9721693D0 (en) 1997-12-10
IL135513A0 (en) 2001-05-20
BG104404A (bg) 2000-12-29
AP2000001787A0 (en) 2000-06-30
HUP0003922A3 (en) 2001-12-28
HUP0003922A2 (hu) 2001-10-28
JP2001519382A (ja) 2001-10-23
AU9547098A (en) 1999-05-03

Similar Documents

Publication Publication Date Title
KR100666591B1 (ko) 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
JP2005213273A (ja) チアゾリジンジオン、インスリン分泌促進薬およびジグアニドを用いる糖尿病の治療
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
SK179499A3 (en) The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
US20020137773A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
SK5312000A3 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
SK5322000A3 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
US20010031776A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003634A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003633A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AU4587002A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AU4586902A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
US20010034356A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
MXPA99012098A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
CZ2000174A3 (cs) Farmaceutický prostředek proti diabetů mellitus a stavům s ním spojeným
MXPA99012078A (en) Treatment of diabetes with thiazolidinedione and metformin